NCT04613141.

Study name	The WalkingTall Study: comparing WalkingTall with Parkinson's Disease (WalkingTall‐PD) with mobility‐plus to reduce falls and improve mobility. (WalkingTall‐PD)
Methods	RCT
Participants	Target sample size: 60 Inclusion criteria: idiopathic Parkinson's disease, Hoehn and Yahr stage 1‐4, ability to walk 18 meters with or without an aid, at least one fall in the past 6 months, or at least 2 falls in the past 12 months, or severe mobility impairment such as freezing of gait, or history of near falls, being stable on anti‐Parkinsonian medications for > 1 month, living independently in the community or retirement village, able to communicate in English language. Exclusion criteria: other neurological and/ or significant cognitive impairments (Montreal Cognitive Assessment < 19 points), atypical Parkinsonism, less than 6 months post deep brain stimulation surgery, > 12 falls in the past 6 months, insufficient foot/ ankle sensation, unable to speak English, another medical condition besides Parkinson's disease that significantly impairs mobility, balance or ability to exercise safely, participating in a different study to improve mobility or prevent falls.
Interventions	1. Walking Tall‐PD program involving smart socks that deliver haptic stimuli timed with preferred cadence and auditory cues via a smartphone app.This is combined with stepping, walking and balance training via the app. 2. Control: Sham exercise using non‐slip socks and a paper‐based low intensity exercise program plus Parkinson's disease health information.
Outcomes	1. Rate of falls 2. Health‐related quality of life (EQ‐5D) Other outcomes not relevant to this review
Starting date	July 15, 2021
Contact information	Dr Matthew Brodie Neuroscience Research Australia Email: a.m.brodie@unsw.edu.au
Notes